Do parathyroid hormone and 1,25-dithydroxyvitamin D modulate bone formation in uremia?
D000328:Adult; D001842:Bone and Bones / Q000187:drug effects / Q000503:physiopathology*; D002117:Calcitriol; D004100:Dihydroxycholecalciferols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010002:Osteitis Fibrosa Cystica / Q000150:complications / Q000503:physiopathology*; D010018:Osteomalacia / Q000150:complications / Q000503:physiopathology*; D010281:Parathyroid Hormone / Q000097:blood / Q000627:therapeutic use*; D010710:Phosphates / Q000097:blood; D014511:Uremia / Q000097:blood / Q000150:complications / Q000188:drug therapy*
D004100:Dihydroxycholecalciferols; D006887:Hydroxycholecalciferols; D010281:Parathyroid Hormone; D010710:Phosphates; D002117:Calcitriol